Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. - Wikidata - awgldk - TriplyDB

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

http://www.wikidata.org/entity/Q33215831

about

Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer Metabolic syndrome and renal cell carcinoma Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells.Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.The potential of antidiabetic thiazolidinediones for anticancer therapy.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Chondrosarcoma and peroxisome proliferator-activated receptor.Thiazolidinediones as anti-cancer agents.PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Relationship between arachidonic acid pathway and human renal cell carcinoma.Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.New insights into antidiabetic drugs: Possible applications in cancer treatment.Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis.Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5, 7-dihydroxy-8-nitrochrysin in vitro.Pioglitazone induces apoptosis of macrophages in human adipose tissue.Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells.Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways

P2860

Q21260390-67794CD8-461E-4130-BA31-0E6F78BF7F63 Q21328702-F8BF2AC8-2461-4F69-9398-D067C90FFF57 Q26825147-123B4592-D15E-40DF-A254-F61FB50E7B79 Q33236656-6564B580-B71B-473C-8C1C-DBE188A3958A Q33809071-8B7C6E9A-2CAF-4FBC-9A10-18F74B49B66D Q34565890-20B5DB0A-8448-4ED5-B8FC-7F4C5841D350 Q36296641-80ADDC8A-1671-4B24-A491-6A84F2643841 Q36392814-4A9DEE78-A09B-4E17-89D0-84C44996DCC0 Q36568732-91ACAD4D-68FE-4774-8135-358DFFFD30D7 Q36661722-87FD5EA6-87B8-4655-8DF7-D5A2D4F0BDD7 Q36795404-9D17A4EB-1938-4941-AE27-E9521ACC2276 Q36840323-1CFE8D27-2ED7-4CF7-AA5C-08A27300FB24 Q37010188-9858ADAD-1516-45DC-9E2F-8A037ABD294F Q37632735-19914DAB-A8FD-4F85-9457-5A17BC3A43B0 Q37656960-7F805DBF-4496-46FD-871B-01AB0DE4CE1C Q37815383-69D7F2CD-1518-4900-89D6-10DC7CE119D4 Q38744037-A872D91B-6654-476A-92C0-92E7A33F7957 Q38909191-F2150D24-FE39-4A7B-9462-8915127FBC55 Q39008676-BB4D1E95-1BF6-49E8-8571-8D29D5038961 Q39239818-904CB3C5-4B23-4B52-85A6-2457FF9C3E6E Q39272833-CD798510-FE75-46E3-B9D7-63928A589BF0 Q39639581-C0973BDC-A982-4B5A-8441-39463F4C1EC8 Q39818168-C48D7CE6-9238-4CCE-8410-55407ACC3FD0 Q39992582-E94A280D-F6AA-421F-B183-D224C3FB93C0 Q40101615-6D09A34A-1217-41BF-8AD6-8611001CDF9A Q40262958-5E674BF1-725B-4367-8739-C6EC3154F450 Q43158772-257B9B4B-78A0-460B-9128-16A1B0C7E4B7 Q58796043-97A44C03-C8C9-4595-A484-DA4BFE5FF519

P2860

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

http://www.wikidata.org/entity/Q33215831

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@ast

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@en

type

label

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@ast

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@en

prefLabel

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@ast

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@en

P1433

Q33215831-FCEAF4D5-C1CD-4CEA-83DC-E43BA117D4E3

P1476

Q33215831-0CD6FF6E-FF41-446C-BC9B-95F385A9569C

P2093

Q33215831-12CFD705-9683-4BB4-9B39-8DA5B699AB25

Q33215831-56B46291-35AB-4044-AFC9-A846E0428246

Q33215831-87D0024F-CEC4-4411-B41B-128E542165EA

Q33215831-979D78C1-C428-4FDC-8E4B-B8099617C689

Q33215831-AC1EB88B-4426-44B7-8A48-DDDF8AE0F46E

Q33215831-B73AE051-7C8F-41AB-ABDC-C7C58CF40E5D

Q33215831-E5478358-3F7B-49D4-B721-B23E15328D4E

P2860

Q33215831-05240586-EA8B-4EFB-A721-596425851459

Q33215831-1227D928-FFCE-4779-BE2B-D7102FB462FA

Q33215831-1ADE6ECE-B003-45FF-BF47-1FF895BEA1D4

Q33215831-20D1D5C7-9C46-4297-921C-DDAD10AABAB2

Q33215831-216F51C3-D6E3-40D8-984E-14D965DBAC2A

Q33215831-2456B4CD-4A74-4D67-81A6-857A69ED266B

Q33215831-258F4180-7C92-4932-B766-502A00421884

Q33215831-277A49EB-8F9E-4572-A8F9-2E246796934E

Q33215831-33A9C40F-A003-47FA-B19F-C80F624E23AA

Q33215831-38F0A2BC-FB69-4AB8-ADD9-28C99E604E46

P2888

Q33215831-C8A56846-A147-4988-B57C-48011FF14BFB

P304

Q33215831-B7877428-9C77-4818-94EE-F159FD173479

P31

Q33215831-34B0C42F-49D9-4B60-A02F-20CB81C92214

P356

Q33215831-E71052AC-4F7A-4B55-8DC5-D96845FD8739

P433

Q33215831-377157E0-F8BC-4383-8AC8-7BAD48B9BB22

P478

Q33215831-600D8FCE-2BB6-460B-B745-540AE9E777D5

P577

Q33215831-79F12007-2296-42C5-ADD3-7DAFE0FFC813

P5875

Q33215831-1349A04F-5AA2-42A5-BDC0-BB8A78A8DDB3

P6179

Q33215831-5644AD31-11B6-4D5B-A8C6-0ADEC767421F

P698

Q33215831-A6544D2C-FD4F-4B96-9343-CF306D4598BB

P356

J.1745-7254.2005.00753.X

P1433

Acta Pharmacologica Sinica

P1476

Peroxisome proliferator-activa ...... an renal carcinoma cell lines.

@en

P2093

Chang-jin Shi

http://www.w3.org/2001/XMLSchema#string

Dian-qi Xin

http://www.w3.org/2001/XMLSchema#string

Feng-guang Yang

http://www.w3.org/2001/XMLSchema#string

Jie-ping Wu

http://www.w3.org/2001/XMLSchema#string

Ying-lu Guo

http://www.w3.org/2001/XMLSchema#string

You-fei Guan

http://www.w3.org/2001/XMLSchema#string

Zhi-wen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.

The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis.

Four-dimensional control of the cell cycle.

Adipogenesis and fat-cell function in obesity and diabetes.

P2888

j.1745-7254.2005.00753.x

P304

753-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1745-7254.2005.00753.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7824494

http://www.w3.org/2001/XMLSchema#string

P6179

1006719537

http://www.w3.org/2001/XMLSchema#string

P698

15916743

http://www.w3.org/2001/XMLSchema#string